7,379 Marsh & McLennan Companies, Inc. $MRSH Shares Sold by TD Waterhouse Canada Inc.

TD Waterhouse Canada Inc. lessened its position in Marsh & McLennan Companies, Inc. (NYSE:MRSH) by 4.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 159,335 shares of the financial services provider’s stock after selling 7,379 shares during the quarter. TD Waterhouse Canada Inc.’s holdings in Marsh & McLennan Companies were worth $27,404,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also added to or reduced their stakes in the company. SHP Wealth Management purchased a new position in shares of Marsh & McLennan Companies in the 4th quarter worth about $26,000. Asset Dedication LLC purchased a new position in shares of Marsh & McLennan Companies during the 1st quarter valued at about $25,000. Pinnacle Bancorp Inc. purchased a new position in shares of Marsh & McLennan Companies during the 1st quarter valued at about $28,000. Canton Hathaway LLC bought a new stake in Marsh & McLennan Companies in the 1st quarter worth approximately $28,000. Finally, Bayban bought a new stake in Marsh & McLennan Companies in the 4th quarter worth approximately $34,000. Hedge funds and other institutional investors own 87.99% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have commented on MRSH shares. Bank of America reduced their price target on shares of Marsh & McLennan Companies from $179.00 to $178.00 and set an “underperform” rating on the stock in a research report on Wednesday, July 15th. BMO Capital Markets lowered their price objective on shares of Marsh & McLennan Companies from $203.00 to $179.00 and set a “market perform” rating for the company in a report on Thursday, October 1st. Erste Group Bank upgraded shares of Marsh & McLennan Companies to a “strong-buy” rating in a report on Tuesday, September 8th. Keefe, Bruyette & Woods cut their price objective on shares of Marsh & McLennan Companies from $203.00 to $202.00 in a research note on Wednesday, August 26th. Finally, UBS Group increased their target price on shares of Marsh & McLennan Companies from $216.00 to $222.00 and gave the company a “buy” rating in a report on Tuesday, October 6th. Two investment analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating, twelve have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $203.60.

Key Headlines Impacting Marsh & McLennan Companies

Here are the key news stories impacting Marsh & McLennan Companies this week:

• Positive Sentiment: Q3 earnings and revenue exceeded expectations. Marsh reported adjusted EPS of $2.03, above the $1.96 consensus, while revenue reached $6.86 billion, an 8.1% year-over-year increase. Growth in Consulting and Risk and Insurance Services helped offset higher operating expenses. Marsh Reports Third Quarter 2026 Results
• Positive Sentiment: Management highlighted continued growth and execution. CEO John Doyle cited 5% underlying revenue growth, double-digit EPS growth, progress on the Thrive program and completion of the company’s brand transition. The earnings call also emphasized artificial intelligence initiatives and a new resilience coalition focused on rising global business risks. Marsh & McLennan Earnings Call Highlights Growth, AI Focus
• Positive Sentiment: Analysts raised their valuation targets. Citigroup increased its target from $200 to $203, while Wells Fargo raised its target from $183 to $197. Both firms retained neutral or equal-weight ratings, suggesting improved expectations but limited conviction for significant outperformance.
• Neutral Sentiment: Analyst opinion remains cautious. RBC Capital maintained its hold rating, and the latest targets remain close to the stock’s recent trading range. This indicates that the earnings beat has improved estimates without substantially changing the broader valuation debate. RBC Capital Maintains Hold Rating
• Negative Sentiment: Challenging operating conditions and higher costs remain risks. Commentary indicates that the difficult operating environment may persist, while rising expenses could pressure margins and reduce the benefit of revenue growth. Challenging Operating Environment Likely to Persist

Insiders Place Their Bets

In other Marsh & McLennan Companies news, SVP Paul Beswick sold 713 shares of the stock in a transaction that occurred on Wednesday, July 29th. The stock was sold at an average price of $198.00, for a total value of $141,174.00. Following the completion of the sale, the senior vice president owned 16,376 shares in the company, valued at approximately $3,242,448. This trade represents a 4.17% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Martin South sold 7,100 shares of Marsh & McLennan Companies stock in a transaction that occurred on Tuesday, July 28th. The stock was sold at an average price of $189.99, for a total value of $1,348,929.00. Following the completion of the sale, the insider owned 16,632 shares in the company, valued at approximately $3,159,913.68. This represents a 29.92% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 19,813 shares of company stock worth $3,597,903. 0.38% of the stock is currently owned by company insiders.

Marsh & McLennan Companies Trading Up 1.1%

Shares of NYSE:MRSH opened at $188.65 on Friday. The company has a current ratio of 1.09, a quick ratio of 1.14 and a debt-to-equity ratio of 1.27. The company’s 50-day moving average price is $181.17. The company has a market capitalization of $90.03 billion, a P/E ratio of 22.57, a price-to-earnings-growth ratio of 2.62 and a beta of 0.59. Marsh & McLennan Companies, Inc. has a 12 month low of $156.60 and a 12 month high of $198.49.

Marsh & McLennan Companies (NYSE:MRSH) last posted its earnings results on Thursday, October 15th. The financial services provider reported $2.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.96 by $0.07. Marsh & McLennan Companies had a return on equity of 33.32% and a net margin of 14.20%. The company had revenue of $6.86 billion for the quarter. Marsh & McLennan Companies’s revenue was up 8.1% compared to the same quarter last year. As a group, research analysts forecast that Marsh & McLennan Companies, Inc. will post 10.45 EPS for the current fiscal year.

Marsh & McLennan Companies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Thursday, October 1st will be issued a $0.99 dividend. The ex-dividend date is Thursday, October 1st. This represents a $3.96 annualized dividend and a yield of 2.1%. Marsh & McLennan Companies’s dividend payout ratio (DPR) is 48.41%.

About Marsh & McLennan Companies

Marsh & McLennan Companies is a global professional services firm that provides advice and solutions in risk, strategy and people. The company serves businesses, governments and institutions through a portfolio of specialized businesses focused on insurance brokerage, reinsurance, consulting and talent management.

Its principal businesses include Marsh, an insurance brokerage and risk advisory firm; Guy Carpenter, a provider of reinsurance brokerage and related risk-management services; Mercer, which offers consulting in investment, retirement, health and workforce strategy; and Oliver Wyman, a management consulting firm serving clients across industries and regions.

Founded in 1905, Marsh & McLennan serves clients in countries and markets around the world.